Skip to main content

Molecular IT, industrialized

Molecular IT moves your critical information into synthetic DNA, giving enterprise IT a durable, offline layer that lasts for centuries, needs almost no energy or space, and stays beyond attackers' reach.

DNA double helix illustration
Zero energy, lifetime data retention icon
Unmatched data durability icon
Eurofins Genomics certification icon
Biomemory vision illustration
Our vision

Molecular storage extends silicon, it does not replace it

Global data creation is exploding. Only 30% of the world’s data is durably stored. Data centers already consume around 2% of global electricity. As volumes double every few years, the silicon-based storage model is reaching structural limits.

DNA introduces a fundamentally different data storage paradigm. By combining molecular stability with modular, data center-compatible system architecture, it enables a new storage tier optimized for extreme density, long-term readability, and structural energy efficiency.

Molecular storage does not replace silicon. It extends it. The data centers of the future will integrate electronic and molecular layers, each designed for its optimal role. DNA becomes the ultra-durable, ultra-dense foundation within a multi-tier infrastructure.

DNA Data Storage is the first industrial step toward molecular Information Systems, where preservation, search, and computation ultimately converge.

Our solutions

Some information has to outlive the system that created it

Storage is specializing, and DNA is among the densest, most durable, and most sovereign of the emerging media now crossing from the laboratory into commercial products. Some records outlive the institutions and systems that made them, and the value they carry is trust over time, not capacity.

Biomemory solution illustration
Inside Biomemory's DNA synthesis machine
Who we are

Biomemory is industrializing DNA as a new information tier : Molecular IT.

Data is stored in synthetic DNA and, increasingly, searched and computed on. Spun out of Sorbonne University and CNRS, we own the full stack, from molecular biology to enterprise software, and, following the Catalog assets acquisition, industrial production in Boston. We are a leader in commercial DNA data storage and co-chair of the DNA Data Storage Alliance.

Close-up of Biomemory's DNA storage hardware
What we make

We enter the market through sovereign data protection and trust preservation

DNA Shield is our entry point: a managed service for sovereign data protection, designed to hold small, irreplaceable data offline and separated from the systems it protects. It is the first rung on a roadmap that extends into storage and, beyond it, into search and compute.

Density statement

DNA holds one million times more data per unit volume than physical data storage. That is why DNA is worth industrializing

Sources : www.science.org, www.nature.com, www.giving.columbia.edu

Our story

Beyond silicon

2021 - From research to reality

Biomemory spins out of CNRS and Sorbonne University, building on years of academic research. Its technology is demonstrated through a landmark project: storing the French Declaration of the Rights of Man and of the Citizen and the Declaration of the Rights of Woman in DNA, with copies preserved by the French National Archives.

2024 - €18M to turn technology into products

Biomemory raises €18 million from Bpifrance, Crédit Mutuel Innovation, Blast and other investors. The funding accelerates technology development and, critically, its productization, turning scientific breakthroughs into deployable DNA Data Storage solutions and enabling the company to engage its first customers.

March 2026 - Scaling up with Catalog’s technology and expertise

Biomemory acquires key assets from Catalog, significantly expanding its capabilities and intellectual property portfolio to more than 90 patents. The acquisition also brings world-class DNA Data Storage experts into the team and establishes a production and R&D footprint in Boston, alongside its Paris operations.

June 2026 - Opening a new route to enterprise customers

Biomemory signs its first partnership with a cloud and data storage provider, Scality. The collaboration creates an additional route into enterprise IT environments, complementing Biomemory’s direct sales model and paving the way for DNA Data Storage to integrate with existing storage infrastructures.

October 2026 - DNA Shield launch

Biomemory launches the world's first DNA data storage service with DNA Shield. DNA Shield is a managed service for sovereign data protection. It is designed to hold small, irreplaceable data offline, in-jurisdiction, and separated from the systems it protects.

Locations

Europe and North America

Biomemory Paris office

Paris

Headquarters and DNA research

5 impasse Reille, 75014 Paris, France

Boston waterfront, home of Biomemory's DNA production site

Boston

DNA production and research

529 Main Street, Suite 125 (AKA 1025), Charlestown, MA 02129 USA